{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:08Z","timestamp":1761630608190},"reference-count":13,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1461,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1529-8019.2012.01472.x","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T17:17:24Z","timestamp":1329844644000},"page":"498-500","source":"Crossref","is-referenced-by-count":8,"title":["Marked improvement in nail psoriasis during treatment with etanercept"],"prefix":"10.1155","volume":"24","author":[{"given":"MERCEDES","family":"G\u00d3MEZ V\u00c1ZQUEZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAM\u00d3N","family":"NAVARRA AMAYUELAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,2,21]]},"reference":[{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB1|cit1","first-page":"1","article-title":"Nail psoriasis and Biologics","volume":"12","author":"Noiles","year":"2008","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1529-8019.2007.00112.x","article-title":"Biological therapy and nail psoriasis","volume":"20","author":"Lawry","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/keh198","article-title":"Extended report: nail disease in psoriatic arthritis-clinically important, potencially treatable and often overlooked","volume":"43","author":"Williamson","year":"2004","journal-title":"Rheumatology"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2310\/7750.2009.00027","article-title":"Psoriatic nail disease: quality of life and treatment","volume":"13","author":"Gupta","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB7|cit7","first-page":"1452","article-title":"Therapies for psoriatic nail disease. A systematic review","volume":"33","author":"Cassell","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB8|cit8","first-page":"34","article-title":"Diagnosis and management of nail psoriasis","volume":"99","author":"Sanchez-Rega\u00f1a","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB9|cit9","unstructured":"de Rie M Giannetti A Walker S et\u2003al Nail psoriasis improves after 12 week of etanercept therapy in patients with moderate to severe psoriasis 2007"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB10|cit10","unstructured":"Rich P Gupta A Wang A et\u2003al Etanercept improves nail psoriasis 2005"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB11|cit11","first-page":"544","article-title":"Rapid response of nail psoriasis to Etanercept","volume":"35","author":"Rallis","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2004.09.012","article-title":"Remission and time of resolution of nail psoriasis during infliximab therapy","volume":"52","author":"Bianchi","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01472.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2133.2008.08686.x","article-title":"Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study","volume":"159","author":"Rigopoulos","year":"2008","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2012.01472.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2012.01472.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:58:37Z","timestamp":1671818317000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2012.01472.x"}},"subtitle":["Marked improvement in psoriasis with etanercept"],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01472.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}